USA |NASDAQ |USD
| Report Date | Period Ending | EPS Forecast | Last Quarter's EPS | Last Year's EPS |
|---|---|---|---|---|
| Jun 30, 2022 (est) | Mar 31, 2022 | - | $-0.03 | $-0.08 |
| Report Date | Period Ending | Revenue Forecast | Last Quarter’s Revenue | Last Year’s Revenue |
|---|---|---|---|---|
| Jun 30, 2022 (est) | Mar 31, 2022 | - | $260.00 | $0.00 |
Second Sight Medical Products's next estimated earnings date (based on same quarter last year's date) is Jun 30, 2022 for the fiscal quarter ending Mar 31, 2022.
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|
| Period End | # of Analysts | Revenue Forecast | Low Revenue Forecast | High Revenue Forecast |
|---|
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Mar 10, 2022 | Dec 2021 | - | $-0.03 | - |
| Nov 4, 2021 | Sep 2021 | - | $-0.06 | - |
| Sep 30, 2021 | Jun 2021 | - | $-0.06 | - |
| Jun 30, 2021 | Mar 2021 | - | $-0.08 | - |
| Mar 31, 2021 | Dec 2020 | - | $-0.12 | - |
| Dec 31, 2020 | Sep 2020 | - | $-0.06 | - |
| Sep 30, 2020 | Jun 2020 | $-0.41 | $-0.07 | 83.10% |
| Jun 26, 2020 | Mar 2020 | $-0.41 | $-0.57 | -39.02% |
| Mar 19, 2020 | Dec 2019 | $-0.49 | $-0.47 | 4.08% |
| Nov 14, 2019 | Sep 2019 | $-0.48 | $-0.48 | - |
| Aug 6, 2019 | Jun 2019 | $-0.48 | $-0.48 | - |
| May 15, 2019 | Mar 2019 | $-0.48 | $-0.56 | -16.67% |
| Mar 13, 2019 | Dec 2018 | $-0.88 | $-0.88 | - |
| Nov 7, 2018 | Sep 2018 | $-1.12 | $-0.88 | 21.43% |
| Aug 7, 2018 | Jun 2018 | $-1.12 | $-0.88 | 21.43% |
| May 10, 2018 | Mar 2018 | $-0.14 | $-1.36 | -871.43% |
| Mar 7, 2018 | Dec 2017 | $-1.12 | $-1.28 | -14.29% |
| Nov 6, 2017 | Sep 2017 | $-0.13 | $-0.96 | -638.46% |
| Aug 1, 2017 | Jun 2017 | $-1.12 | $-0.86 | 22.90% |
| May 3, 2017 | Mar 2017 | $-1.12 | $-1.18 | -5.71% |
| Mar 9, 2017 | Dec 2016 | $-1.36 | $-1.92 | -41.18% |
| Nov 2, 2016 | Sep 2016 | $-0.16 | $-0.20 | -25.00% |
| Jul 28, 2016 | Jun 2016 | $-1.20 | $-1.36 | -13.33% |
| Apr 28, 2016 | Mar 2016 | $-1.28 | $-1.04 | 18.75% |
| Mar 3, 2016 | Dec 2015 | $-1.12 | $-1.04 | 7.14% |
| Oct 29, 2015 | Sep 2015 | $-0.14 | $-0.13 | 7.14% |
| Aug 4, 2015 | Jun 2015 | - | $-1.11 | - |
| May 13, 2015 | Mar 2015 | - | $-1.12 | - |
| Mar 11, 2015 | Dec 2014 | - | $-3.68 | - |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Mar 10, 2022 | Dec 2021 | $0.00 | $-0.24 | - |
| Mar 31, 2021 | Dec 2020 | $0.00 | $-0.82 | - |
| Mar 19, 2020 | Dec 2019 | $-2.22 | $-1.99 | - |
| Mar 13, 2019 | Dec 2018 | $-0.52 | $-4.00 | - |
| Mar 7, 2018 | Dec 2017 | $-0.55 | $-4.29 | - |
| Mar 9, 2017 | Dec 2016 | - | $-4.52 | - |
| Mar 3, 2016 | Dec 2015 | - | $-3.40 | - |
| Mar 11, 2015 | Dec 2014 | - | $-3.68 | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Mar 10, 2022 | Dec 2021 | - | $260.00 | - |
| Nov 4, 2021 | Sep 2021 | - | $0.00 | - |
| Sep 30, 2021 | Jun 2021 | - | $0.00 | - |
| Jun 30, 2021 | Mar 2021 | - | $0.00 | - |
| Mar 31, 2021 | Dec 2020 | $0.00 | $0.00 | - |
| Dec 31, 2020 | Sep 2020 | $240.00K | $0.00 | - |
| Sep 30, 2020 | Jun 2020 | $240.00K | $0.00 | - |
| Jun 26, 2020 | Mar 2020 | $240.00K | $497.00K | 2.07% |
| Mar 19, 2020 | Dec 2019 | $470.00K | $497.00K | 1.06% |
| Nov 14, 2019 | Sep 2019 | $940.00K | $472.00K | 0.50% |
| Aug 6, 2019 | Jun 2019 | $450.00K | $1.28M | 2.85% |
| May 15, 2019 | Mar 2019 | $1.66M | $1.13M | 0.68% |
| Mar 13, 2019 | Dec 2018 | $2.64M | $1.77M | 0.67% |
| Nov 7, 2018 | Sep 2018 | $2.48M | $2.25M | 0.91% |
| Aug 7, 2018 | Jun 2018 | $2.21M | $1.91M | 0.86% |
| May 10, 2018 | Mar 2018 | $976.00K | $976.00K | 1.00% |
| Mar 7, 2018 | Dec 2017 | $2.00M | $3.11M | 1.55% |
| Nov 6, 2017 | Sep 2017 | $1.61M | $1.61M | 1.00% |
| Aug 1, 2017 | Jun 2017 | - | $2.24M | - |
| May 3, 2017 | Mar 2017 | - | $1.01M | - |
| Mar 9, 2017 | Dec 2016 | - | $715.00K | - |
| Nov 2, 2016 | Sep 2016 | - | $1.18M | - |
| Jul 28, 2016 | Jun 2016 | - | $1.04M | - |
| Apr 28, 2016 | Mar 2016 | - | $1.05M | - |
| Mar 3, 2016 | Dec 2015 | - | $2.36M | - |
| Oct 29, 2015 | Sep 2015 | - | $2.23M | - |
| Aug 4, 2015 | Jun 2015 | - | $2.66M | - |
| May 13, 2015 | Mar 2015 | - | $1.70M | - |
| Mar 11, 2015 | Dec 2014 | - | $1.52M | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Mar 10, 2022 | Dec 2021 | $240.00K | $260.00 | - |
| Mar 31, 2021 | Dec 2020 | $0.00 | $1.00K | - |
| Mar 19, 2020 | Dec 2019 | $3.35M | $3.38M | 0.87% |
| Mar 13, 2019 | Dec 2018 | $7.76M | $6.90M | -11.13% |
| Mar 7, 2018 | Dec 2017 | $6.80M | $7.96M | 17.12% |
| Mar 9, 2017 | Dec 2016 | - | $3.98M | - |
| Mar 3, 2016 | Dec 2015 | - | $8.95M | - |
| Mar 11, 2015 | Dec 2014 | - | $3.40M | - |
EYES's next estimated earnings date (based on same quarter last year's report date) is Jun 30, 2022 for the fiscal quarter ending Mar 31, 2022.
Second Sight Medical Products's previous earnings date was Mar 10, 2022 for its fiscal quarter ended Dec 31, 2021.
EYES's earnings per share (EPS) was $-0.03.
The EPS was higher than the previous fiscal quarter (Sep 2021) by -48.66%, and higher than the same period a year before (Dec 2020) by -73.01%.
Revenues were $260.00.
The company reported a net income of $-8.92K.Free cash flow for the quarter was $-2.44M , compared to $-1.80M last quarter and $-1.45M a year before.
EYES ended the quarter with $237.00K in total debt, a decrease of -15.66% compared to the previous quarter, and a decrease of -89.23% compared to the same quarter a year before.
Second Sight Medical Products's previous annual earnings date was Mar 10, 2022 for its fiscal year ended Dec 31, 2021.
EYES's earnings per share (EPS) was $-0.24.
Revenues were $260.00, down by -74.00% from previous year's revenue.
The company reported a net income of $-8.92K.
Second Sight Medical Products reported a free cash flow of $-9.20M for its fiscal year, compared to $-17.15M a year ago.
The company ended the fiscal year with $237.00K in total debt, a decrease of -89.23% compared to the previous year.
Get a weekly snapshot of one new investment idea from stock exchanges worldwide.
